The candidate will work to lower the cost of prescription drugs by increasing access to biosimilars and encouraging competition.

We also need to lower the cost of prescription drugs, and I have introduced the bipartisan Increasing Access to Biosimilars Act to help reduce the cost of prescription drugs by encouraging competition and increasing access to biosimilars.

Commits to reducing prescription drug costs through biosimilar competition and broader access.

A Health Care System That Works for Everyone - Brian Fitzpatrick For Congress
campaign · campaign_site · model gpt-5.4-mini

Rep. Fitzpatrick announced the Fair Drug Prices For Kids Act, saying it would let states purchase medications for standalone CHIP programs at the Medicaid best price and ensure families have access to prescription drugs at the lowest price offered.

Shows Fitzpatrick taking concrete legislative action to lower prescription drug costs by leveraging lower prices from manufacturers, which aligns with the promise to encourage competition on drug pricing.

partial same_term A for effort

Fitzpatrick, Wild Lead Bipartisan Legislation to Lower Prescription Drug Costs for Children
secondary · model gpt-5.4-mini · confidence 92%

Fitzpatrick said his Health Insurance Price Transparency Act would help patients make better informed decisions, shop around for the best option, and understand how much a health service will cost them.

This is direct evidence that Fitzpatrick pursued market transparency as a way to increase consumer choice and competition in health care pricing, though it is not specific to biosimilars.

partial same_term A for effort

Fitzpatrick Introduces Bipartisan Legislation to Increase Transparency in Health Insurance Pricing
secondary · model gpt-5.4-mini · confidence 86%

Fitzpatrick introduced the HELP Copays Act, which would require insurers and PBMs to count copay assistance toward cost-sharing limits and describes the bill as a patient-first reform to lower out-of-pocket costs.

Shows continued effort to reduce prescription-drug costs through legislation. The measure is about copay assistance rather than biosimilars, but it is further evidence of a continuing cost-reduction agenda.

partial same_term A for effort

Fitzpatrick Leads Bipartisan Effort to Protect Patients from High Prescription Drug Costs | Press Releases | Congressman Brian Fitzpatrick
secondary · model gpt-5.4-mini · confidence 78%